SEC Form 4 · accession 0001179110-18-002688
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce Leicher
Officer — SVP & General Counsel
Period of report
Feb 21, 2018
Accepted (ET)
Feb 23, 2018 · 12:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 21, 2018 | S | 377 | $15.90 | D | 171,194 | D | |
| Common Stock | Feb 21, 2018 | S | 351 | $15.90 | D | 170,843 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan.